CONDENSED CONSOLIDATED INTERIM STATEMENTS OF LOSS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2026	Apr. 30, 2025	Apr. 30, 2026	Apr. 30, 2025
EXPENSES
Accretion expense	$ 0	$ 63,765	$ 8,018	$ 222,460
Consulting	29,110	49,769	307,204	171,659
Directors' fees	38,667	20,000	78,667	70,000
Filing and regulatory	9,994	5,341	54,069	41,261
Foreign exchange (gain) loss	1,167	360	4,968	5,773
General and administrative	35,013	72,171	178,245	197,143
Geological, mineral, and prospect costs	186,207	7,131	284,832	72,984
Interest expense	0	55,592	3,915	220,708
Professional fees	330,423	104,335	1,194,734	329,909
Promotion and shareholder communication	0	6,525	62,000	20,908
Salaries	42,565	0	82,348	0
Share-based compensation	26,249	59,696	1,076,226	258,415
Loss	(699,395)	(444,685)	(3,335,226)	(1,611,220)
Impairment of deferred financing asset	0	0	(67,610)	0
Impairment of assets held for sale	0	(311,530)	0	(311,530)
Loss on note receivable	0	0	0	(155,727)
Other income	84,593	181	204,426	7,717
Net loss and comprehensive loss for the period	$ (614,802)	$ (756,034)	$ (3,198,410)	$ (2,070,760)
Basic loss per common share	$ (0)	$ (0.01)	$ (0.03)	$ (0.04)
Diluted loss per common share	$ (0)	$ (0.01)	$ (0.03)	$ (0.04)
Weighted average number of common shares outstanding, basic	125,580,034	55,785,106	114,407,189	55,785,106
Weighted average number of common shares outstanding, diluted	125,580,034	55,785,106	114,407,189	55,785,106